Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria | Hypertension
Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer | Circulation: Cardiovascular Quality and Outcomes
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
A practical guide to medicines for chronic kidney disease
Should an ACE inhibitor be stopped if signs of renal insufficiency appear? | Cleveland Clinic Journal of Medicine
Angiotensin and the Coronavirus | Science | AAAS
Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
The management of end-stage heart failure and reducing the risk of cardiorenal syndrome | RCP Journals
Frontiers | Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition | Hypertension Research
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology
COVID-19 - Renin-Angiotensin System Drugs - NECS Medicines Optimisation
ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction - ScienceDirect
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial - The Lancet Respiratory Medicine
Choice of drug therapy in primary (essential) hypertension - UpToDate
NKF KDOQI Guidelines
Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease | NEJM
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers - BJA Education
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect
ACE Inhibitor Pathway, Pharmacodynamics
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death - ScienceDirect
What Is an Angiotensin Converting Enzyme Inhibitor? | Circulation
Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde? | SpringerLink
